Cyrus Bio Leads Computational Protein Engineering Panel

SEATTLE, October 17, 2017 — Lucas Nivon, CEO of Cyrus Biotechnology, today will lead a panel on recent advances in computational protein engineering at LabCentral in Cambridge, MA.


Computationally designed therapeutic proteins are in the clinic, and computationally optimized enzymes are producing ingredients of value sustainably and cost effectively. Dr. Nivon will present an overview of published and experimentally verified advances in computational protein engineering, and will demonstrate some modeling workflows with sample software based on the Rosetta protein modeling toolkit first developed at Professor David Baker’s laboratory at the University of Washington. Following Dr. Nivon’s overview, four panelists from Manus Biosynthesis, Moderna Therapeutics, Northeastern University and UMass Dartmouth will present various examples of protein modeling.


In addition to LabCentral, this event has been publicized on Mass Bio and Mass Life Sciences Center web sites.


Click here for registration and full abstracts.